MedPath

Oxford Pharmaceuticals, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

FDA:11

Drug Approvals

Spironolactone

Approval Date
Mar 27, 2024
FDA

Methocarbamol

Approval Date
Mar 6, 2024
FDA

Buspirone Hydrochloride

Approval Date
Feb 5, 2024
FDA

AMLODIPINE BESYLATE

Approval Date
Jan 26, 2024
FDA

Sotalol Hydrochloride

Approval Date
Nov 2, 2023
FDA

Trazodone Hydrochloride

Approval Date
Jan 19, 2023
FDA

paroxetine hydrochloride

Approval Date
Nov 1, 2022
FDA

Primidone

Approval Date
Apr 5, 2022
FDA

Dipyridamole

Approval Date
Mar 29, 2021
FDA

Hydrochlorothiazide

Approval Date
Aug 31, 2020
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.